Metralindole

DB09306ExperimentalSmall molecule

Metralindole, also known as Inkazan, is similar in structure and pharmacology to pirlindole. It functions as a reversible inhibitor of monoamine oxidase A. In Russia, this drug was investigated for...

Primary indication: Investigated for the treatment of depression.Curator reviewed
Formula / weight: C₁₅H₁₇N₃O · 255.321 g/mol (avg)
Also known as: Incasan · Inkazan

Resolves to

Compound

UNII2QW3FL6OPACAS54188-38-4ChEMBLCHEMBL1619017ChEBI135044PubChem68713

Structure

InChIKeyGVXBHSBKKJRBMS-UHFFFAOYSA-NSMILESCOC1=CC2=C(C=C1)N1CCN(C)C3=NCCC2=C13

Targets

P24941CDK2P68400CSNK2A1

What you can answer from here — as of October 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Metralindole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account